Compare LTRN & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LTRN | XBP |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.6M | 41.3M |
| IPO Year | 2020 | 2021 |
| Metric | LTRN | XBP |
|---|---|---|
| Price | $1.00 | $3.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.50 | N/A |
| AVG Volume (30 Days) | ★ 236.0K | 21.5K |
| Earning Date | 11-12-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.65 | ★ 183.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $872,690,000.00 |
| Revenue This Year | N/A | $2.47 |
| Revenue Next Year | N/A | $10.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $0.41 |
| 52 Week High | $4.70 | $8.55 |
| Indicator | LTRN | XBP |
|---|---|---|
| Relative Strength Index (RSI) | 18.64 | 56.60 |
| Support Level | N/A | $2.10 |
| Resistance Level | $1.96 | $3.87 |
| Average True Range (ATR) | 0.17 | 0.25 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 4.12 | 44.70 |
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. The segments of the company are Applied Workflow Automation and Technology. The Applied Workflow Automation segment generates maximum revenue and provides services powered by intelligent, AI-enabled workflows that generate outcomes for client's systems, while the Technology segment focuses on the sale of recurring and perpetual software licenses, software maintenance and professional services, as well as hardware solutions and maintenance.